Literature DB >> 35523139

Antigen presentation safeguards the integrity of the hematopoietic stem cell pool.

Pablo Hernández-Malmierca1, Dominik Vonficht1, Alexandra Schnell2, Hannah J Uckelmann3, Alina Bollhagen4, Mohamed A A Mahmoud4, Sophie-Luise Landua4, Elise van der Salm4, Christine L Trautmann4, Simon Raffel5, Florian Grünschläger1, Raphael Lutz6, Michael Ghosh7, Simon Renders6, Nádia Correia4, Elisa Donato4, Karin O Dixon2, Christoph Hirche8, Carolin Andresen1, Claudia Robens4, Paula S Werner8, Tobias Boch9, David Eisel10, Wolfram Osen10, Franziska Pilz8, Adriana Przybylla4, Corinna Klein4, Frank Buchholz11, Michael D Milsom12, Marieke A G Essers8, Stefan B Eichmüller10, Wolf-Karsten Hofmann13, Daniel Nowak13, Daniel Hübschmann14, Michael Hundemer5, Christian Thiede15, Lars Bullinger16, Carsten Müller-Tidow17, Scott A Armstrong3, Andreas Trumpp18, Vijay K Kuchroo19, Simon Haas20.   

Abstract

Hematopoietic stem and progenitor cells (HSPCs) are responsible for the production of blood and immune cells. Throughout life, HSPCs acquire oncogenic aberrations that can cause hematological cancers. Although molecular programs maintaining stem cell integrity have been identified, safety mechanisms eliminating malignant HSPCs from the stem cell pool remain poorly characterized. Here, we show that HSPCs constitutively present antigens via major histocompatibility complex class II. The presentation of immunogenic antigens, as occurring during malignant transformation, triggers bidirectional interactions between HSPCs and antigen-specific CD4+ T cells, causing stem cell proliferation, differentiation, and specific exhaustion of aberrant HSPCs. This immunosurveillance mechanism effectively eliminates transformed HSPCs from the hematopoietic system, thereby preventing leukemia onset. Together, our data reveal a bidirectional interaction between HSPCs and CD4+ T cells, demonstrating that HSPCs are not only passive receivers of immunological signals but also actively engage in adaptive immune responses to safeguard the integrity of the stem cell pool.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD4(+) T cells; acute myeloid leukemia; antigen presentation; hematopoietic stem cells; immune regulation; immunosurveillance; leukemia

Mesh:

Year:  2022        PMID: 35523139      PMCID: PMC9202612          DOI: 10.1016/j.stem.2022.04.007

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   25.269


  94 in total

Review 1.  Hematopoiesis: a human perspective.

Authors:  Sergei Doulatov; Faiyaz Notta; Elisa Laurenti; John E Dick
Journal:  Cell Stem Cell       Date:  2012-02-03       Impact factor: 24.633

2.  Inflammation-Induced Emergency Megakaryopoiesis Driven by Hematopoietic Stem Cell-like Megakaryocyte Progenitors.

Authors:  Simon Haas; Jenny Hansson; Daniel Klimmeck; Dirk Loeffler; Lars Velten; Hannah Uckelmann; Stephan Wurzer; Áine M Prendergast; Alexandra Schnell; Klaus Hexel; Rachel Santarella-Mellwig; Sandra Blaszkiewicz; Andrea Kuck; Hartmut Geiger; Michael D Milsom; Lars M Steinmetz; Timm Schroeder; Andreas Trumpp; Jeroen Krijgsveld; Marieke A G Essers
Journal:  Cell Stem Cell       Date:  2015-08-20       Impact factor: 24.633

3.  Smart-seq2 for sensitive full-length transcriptome profiling in single cells.

Authors:  Simone Picelli; Åsa K Björklund; Omid R Faridani; Sven Sagasser; Gösta Winberg; Rickard Sandberg
Journal:  Nat Methods       Date:  2013-09-22       Impact factor: 28.547

Review 4.  Monocyte differentiation and antigen-presenting functions.

Authors:  Claudia V Jakubzick; Gwendalyn J Randolph; Peter M Henson
Journal:  Nat Rev Immunol       Date:  2017-04-24       Impact factor: 53.106

5.  CD80-Transfected acute myeloid leukemia cells induce primary allogeneic T-cell responses directed at patient specific minor histocompatibility antigens and leukemia-associated antigens.

Authors:  T Mutis; E Schrama; C J Melief; E Goulmy
Journal:  Blood       Date:  1998-09-01       Impact factor: 22.113

6.  HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome.

Authors:  Yogen Saunthararajah; Ryotaro Nakamura; Jun-Mo Nam; Jamie Robyn; Fausto Loberiza; Jaroslaw P Maciejewski; Toni Simonis; Jeffrey Molldrem; Neal S Young; A John Barrett
Journal:  Blood       Date:  2002-09-01       Impact factor: 22.113

7.  Autophagy maintains the metabolism and function of young and old stem cells.

Authors:  Theodore T Ho; Matthew R Warr; Emmalee R Adelman; Olivia M Lansinger; Johanna Flach; Evgenia V Verovskaya; Maria E Figueroa; Emmanuelle Passegué
Journal:  Nature       Date:  2017-03-01       Impact factor: 49.962

Review 8.  A Review of Efficacy and Safety of Checkpoint Inhibitor for the Treatment of Acute Myeloid Leukemia.

Authors:  Dan Liao; Mengyao Wang; Yi Liao; Jun Li; Ting Niu
Journal:  Front Pharmacol       Date:  2019-06-06       Impact factor: 5.810

9.  Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis.

Authors:  Estelle Bettelli; Maria Pagany; Howard L Weiner; Christopher Linington; Raymond A Sobel; Vijay K Kuchroo
Journal:  J Exp Med       Date:  2003-05-05       Impact factor: 14.307

10.  Induction and transcriptional regulation of the co-inhibitory gene module in T cells.

Authors:  Norio Chihara; Asaf Madi; Takaaki Kondo; Huiyuan Zhang; Nandini Acharya; Meromit Singer; Jackson Nyman; Nemanja D Marjanovic; Monika S Kowalczyk; Chao Wang; Sema Kurtulus; Travis Law; Yasaman Etminan; James Nevin; Christopher D Buckley; Patrick R Burkett; Jason D Buenrostro; Orit Rozenblatt-Rosen; Ana C Anderson; Aviv Regev; Vijay K Kuchroo
Journal:  Nature       Date:  2018-06-13       Impact factor: 49.962

View more
  1 in total

1.  Inflammatory exposure drives long-lived impairment of hematopoietic stem cell self-renewal activity and accelerated aging.

Authors:  Ruzhica Bogeska; Ana-Matea Mikecin; Paul Kaschutnig; Malak Fawaz; Marleen Büchler-Schäff; Duy Le; Miguel Ganuza; Angelika Vollmer; Stella V Paffenholz; Noboru Asada; Esther Rodriguez-Correa; Felix Frauhammer; Florian Buettner; Melanie Ball; Julia Knoch; Sina Stäble; Dagmar Walter; Amelie Petri; Martha J Carreño-Gonzalez; Vinona Wagner; Benedikt Brors; Simon Haas; Daniel B Lipka; Marieke A G Essers; Vivienn Weru; Tim Holland-Letz; Jan-Philipp Mallm; Karsten Rippe; Stephan Krämer; Matthias Schlesner; Shannon McKinney Freeman; Maria Carolina Florian; Katherine Y King; Paul S Frenette; Michael A Rieger; Michael D Milsom
Journal:  Cell Stem Cell       Date:  2022-07-19       Impact factor: 25.269

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.